A photo of Esi Morgan.

Clinical Director, Division of Rheumatology

Associate Professor, UC Department of Pediatrics

513-803-2672

Board Certified

Make an Appointment

My Biography & Research

Biography

Esi Morgan, MD, MSCE, is a pediatric rheumatologist and researcher. Clinical care spans the childhood rheumatic diseases, with focus on juvenile idiopathic arthritis (JIA) and juvenile dermatomyositis.

Her research training and experience includes epidemiology and health services research, in addition to specialization in quality improvement methods and application to improve health care delivery. Dr. Morgan leads a research project to develop new measures to assess pain in children and youth, as well as to validate measures of health related quality of life in children with juvenile idiopathic arthritis or chronic pain as part of a national network of investigators.

Dr. Morgan is a leader in a multi-center quality improvement network to improve the outcome of care in children with JIA, the Pediatric-Rheumatology Care and Outcomes Improvement Network. Additionally, she has served on expert panels in development of JIA treatment recommendations and measures of quality of care in treatment of JIA.

Additional Languages

Spanish

Clinical Interests

Childhood rheumatic diseases; juvenile idiopathic arthritis; juvenile dermatomyositis; sarcoidosis

Research Interests

Patient reported outcomes measure development; quality Improvement; health services research; economic evaluations; comparative effectiveness

Academic Affiliation

Associate Professor, UC Department of Pediatrics

Departments

Rheumatology, Lupus, Rheumatology

Cincinnati Children's Blog

8 Misconceptions About Juvenile Idiopathic Arthritis JIA

BlogRare and Complex Conditions

8 Misconceptions About Juvenile Idiopathic Arthritis (JIA)

By Esi Morgan, MD7/30/2019

My Locations

My Education

MD: Washington University School of Medicine, St. Louis, MO, 1999.

Residency: Pediatrics, Children’s Hospital of Philadelphia, Philadelphia, PA, 2002.

Fellowship: Rheumatology, Children’s Hospital of Philadelphia, Philadelphia, PA, 2005.

MSCE: University of Pennsylvania, Center for Clinical Epidemiology & Biostatistics, Philadelphia, PA, 2005.

Certification:  Pediatrics, 2002; Pediatric Rheumatology, 2006.

My Publications

Systemic Juvenile Idiopathic Arthritis-Associated Lung Disease: Characterization and Risk Factors. Schulert, GS; Yasin, S; Carey, B; Chalk, C; Do, T; Schapiro, AH; Husami, A; Watts, A; Brunner, HI; Huggins, J; et al. Arthritis and Rheumatology. 2019; 71:1943-1954.

OMERACT Development of a Core Domain Set of Outcomes for Shared Decision-making Interventions. Toupin-April, K; Barton, JL; Fraenkel, L; Meara, A; Li, LC; Brooks, P; de Wit, M; Stacey, D; Légaré, F; Shea, B; et al. The Journal of rheumatology. 2019; 46:1409-1414.

Establishing an Updated Core Domain Set for Studies in Juvenile Idiopathic Arthritis: A Report from the OMERACT 2018 JIA Workshop. Morgan, EM; Munro, JE; Horonjeff, J; Horgan, B; Shea, B; Feldman, BM; Clairman, H; III, BC O; Thornhill, S; Strand, V; et al. The Journal of rheumatology. 2019; 46:1006-1013.

Utility of the PROMIS Pediatric Pain Interference Scale in Juvenile Fibromyalgia. Fussner, LM; Black, WR; Lynch-Jordan, A; Morgan, EM; Ting, TV; Kashikar-Zuck, S. Journal of Pediatric Psychology. 2019; 44:436-441.

Systemwide Implementation of Patient-Reported Outcomes in Routine Clinical Care at a Children's Hospital. Gerhardt, WE; Mara, CA; Kudel, I; Morgan, EM; Schoettker, PJ; Napora, J; Britto, MT; Alessandrini, EA. The Joint Commission Journal on Quality and Patient Safety. 2018; 44:441-453.

Treating juvenile idiopathic arthritis to target: recommendations of an international task force. Ravelli, A; Consolaro, A; Horneff, G; Laxer, RM; Lovell, DJ; Wulffraat, NM; Akikusa, JD; Al-Mayouf, SM; Anton, J; Avcin, T; et al. Annals of the Rheumatic Diseases. 2018; 77:819-828.

The Childhood Arthritis and Rheumatology Research Alliance Consensus Treatment Plans Toward Comparative Effectiveness in the Pediatric Rheumatic Diseases. Ringold, S; Nigrovic, PA; Feldman, BM; Tomlinson, GA; von Scheven, E; Wallace, CA; Huber, AM; Schanberg, LE; Li, SC; Weiss, PF; et al. Arthritis and Rheumatology. 2018; 70:669-678.

Barriers to Adherence in Juvenile Idiopathic Arthritis: A Multicenter Collaborative Experience and Preliminary Results. Favier, LA; Taylor, J; Rich, KL; Jones, KB; Vora, SS; Harris, JG; Gottlieb, BS; Robbins, L; Lai, JT; Lee, T; et al. The Journal of rheumatology. 2018; 45:690-696.

Treat to Target in Juvenile Idiopathic Arthritis: Challenges and Opportunities. Smitherman, EA; Consolaro, A; Morgan, EM. Current Treatment Options in Rheumatology. 2018; 4:29-43.

Lack of Concordance in Interrater Scoring of the Provider's Global Assessment of Children With Juvenile Idiopathic Arthritis With Low Disease Activity. Taylor, J; Giannini, EH; Lovell, DJ; Huang, B; Morgan, EM. Arthritis Care and Research. 2018; 70:162-166.